Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Healthcare
Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

Bullboard (TSX:NBLY)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Kanatainvestoron Jul 13, 2023 11:29am

RE:RBC Report

Thank you for sharing the report. even at the reduced $28 price target, investors are looking at over 75% return from current levels. Much of the decline in the share price has taken place in low ...more  
65
Discussion
Post by retiredcfon Jul 13, 2023 9:27am

RBC Report

Their upside scenario target is $42.00. GLTA July 12, 2023 Outperform TSX: NBLY; CAD 15.95 Price Target CAD 28.00 ↓ 34.00  ...more  
93
Discussion
Post by incomedreamer11on Jul 13, 2023 8:48am

Royal Bank down price target

RBC analyst Irene Nattel cut her price target on Neighbourly Pharmacy Inc (NBLY-T) to C$28 from C$34 but reiterated an “outperformer” rating after adjusting her assumptions on how quickly ...more  
107
Comment by Kanatainvestoron Jul 06, 2023 4:50pm

RE:Pharmacy chains M&A multiples

I see the image I attached is not showing, you can see it in this link at page 10: https://www.jeancoutu.com/contentassets/5ef7585a7f704363a6217dc997834c07/circular-amalgamation-jcg--metro-inc.pdf
52
Discussion
Post by Kanatainvestoron Jul 06, 2023 4:40pm

Pharmacy chains M&A multiples

Historically, Pharmacy chains exchanged hands at around 12 EBITDA (list below). Today, NBLY is trading at 10 EBITDA, which is materially under the historical average valuations for companies of its ...more  
134
Discussion
Post by retiredcfon Jul 06, 2023 6:33am

Stockchase Insights

HOLD Neighbourly Pharmacy Inc(NBLY-T) 05/07/2023   Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research NBLY has not been a public company for very long (IPO'd in ...more  
172
Post by Kanatainvestoron Jun 30, 2023 9:26am

This stock is poised to reprice higher

I don’t think those bailing understand the degree of operating leverage that can be achieved under NBLY’s roll up model. The previous team was heavily focused on acquisitive growth, the new team has ...more  
149
Post by BSdetector2016on Jun 27, 2023 11:45am

According to TD

Analyst consensus target is $25.17. That's quite a disconnect between reality and crystal ball rubbing.
84
Comment by incomedreamer11on Jun 26, 2023 2:35pm

RE:Entrance point

All supports are broken, put stink bid -14 CAD ,still in their IPO price range  If I will get shares I will take it , no rush to catch falling knife
78
Discussion
Comment by retiredcfon Jun 26, 2023 8:19am

RE:Insider Buying

Here's what he paid per share. GLTA Neighbourly Pharmacy Inc. On June 15, chairman of the board of directors Stuart Elman bought 33,707 shares at a price per share of $17.78 for his RRSP ...more  
97
Discussion
Post by incomedreamer11on Jun 19, 2023 11:38am

Entrance point

IPO price was in range 13-17 CAD, on post-COVID hype oversubscribed with final IPO 17CAD First day of trading around 24 CAD Good entrance point  around 15 CAD 
126
Discussion
Post by retiredcfon Jun 19, 2023 8:50am

Insider Buying

Most active public-market buying insiders (all markets in Canada) From June 12th to June 16th as filed and reported by June 18th (000's): James Pattison bought $7,523 Westshore Terminals ...more  
142
Discussion
Post by retiredcfon Jun 12, 2023 1:24pm

Another View

We simply need "a better market backdrop." GLTA EPS of $0.06 missed estimates of $0.067 and revenues of $190.612M missed estimates of $191.117M. Sales increased substantially for the ...more  
147
Post by incomedreamer11on Jun 12, 2023 9:47am

Another downgrade

Despite calling Neighbourly Pharmacy Inc.’s (NBLY-T) in-line fourth-quarter results “solid,” Desjardins Securities analyst Chris Li wants to “wait for better margin visibility” before raising his ...more  
154
Post by Possibleidiot01on Jun 09, 2023 5:43pm

Analysts

Neighbourly Pharmacy (TSE:NBLY) had its price target lowered by analysts at Scotiabank from C$26.50 to C$24.50. This represents a 29.6% upside from the current price of C$18.90.   ...more  
148
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities